• Asterias Biotherapeutics Inc., of Menlo Park, Calif., a subsidiary of Biotime Inc., said it plans to file a registration statement next month for a public offering of units, each unit consisting of one share of Series B common stock, $0.0001 per value per share and one redemption right in respect of one share of Series B common stock.